FDA
approval
· 2020-04-16
FDA Approved: RUFINAMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
The FDA approved a supplemental application for Rufinamide (Hikma Pharmaceuticals USA Inc.) under ANDA204988, signaling an approved addition or change to the ex…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for RUFINAMIDE (RUFINAMIDE)